Craneware Monthly Analysis (March 2026)

Craneware

AIM:CRW

£ 12,90

£-0,20 (-1,53%)

12,90 £

£-0,20 (-1,53%)

End-of-day quote: 03/30/2026

Craneware Stock Value

Analysts currently see Craneware at the level of Buy.

Buy

Craneware Company Info

EPS Growth 5Y

5,34%

Market Cap

£0,45 B

Long-Term Debt

£0,02 B

Quarterly earnings

06/09/2026 (E)

Dividend

£0,31

Dividend Yield

2,44%

Founded

1999

Industry

Health Care

Country

United Kingdom

Website

Craneware

ISIN Number

GB00B2425G68

Website

http://www.thecranewaregroup.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

£29,35

127.52%

Last Update: 03/31/2026

Analysts: 6

Highest Price Target £33,67

Average Price Target £29,35

Lowest Price Target £28,89

In the last five quarters, Craneware’s Price Target has risen from £27,01 to £28,55 - a 5,70% increase. Six analysts predict that Craneware’s share price will increase in the coming year, reaching £29,35. This would represent an increase of 127,52%.

Top growth stocks in the health care sector (5Y.)

What does Craneware do?

Craneware plc is a recognized leader in the development of software solutions aimed at the healthcare sector. Focusing primarily on revenue integrity and cost management, the company offers a suite of products designed to enhance operational efficiency, improve financial performance, and ensure compliance with healthcare regulations. The main platform, Trisus, provides access to vital data and analytics that enable healthcare organizations to optimize their operations. With a strong emphasis on...

One of the company's core offerings revolves around its ability to deliver insights into financial and operational data. By leveraging advanced analytics, the company delivers solutions that align with healthcare organizations' goals of providing quality care while adhering to fiscal limitations. The company's solutions inform decision-making processes by focusing on revenue cycle management, thereby supporting hospitals and healthcare providers in maintaining financial integrity.

The company emphasizes a partnership approach, recognizing that collaborations with customers and other technology providers contribute to enriched service offerings. The company aims to develop long-term licensing agreements with customers that facilitate ongoing use and renewal of its products, ensuring sustained access to the technology solutions required to thrive in the dynamic healthcare landscape.

Moreover, the company understands the importance of addressing contemporary challenges such as cybersecurity threats. This awareness has driven the development of its platform, which not only focuses on delivering quality solutions but also emphasizes the importance of secure and reliable access to data, thereby building customer trust.

Business Segments

The company operates primarily through its main platform, Trisus, which encompasses a series of specialized application suites. Each suite is geared toward addressing specific needs within the healthcare sector, structured to facilitate comprehensive revenue integrity and cost management. The suite includes applications focused on Pricing Integrity, Data Integrity, Business of Pharmacy, Revenue Protection Optimization, Charge Capture Optimization, and Value-based Margin & Productivity.

The Pricing Integrity suite aids healthcare organizations in managing pricing strategies, ensuring compliance with applicable regulations, and optimizing revenue generation through accurate coding and billing.

Concurrently, the Data Integrity suite is pivotal in assuring that financial and operational data across various platforms is accurate and reliable. This operational insight allows hospitals to make informed decisions surrounding their financial strategies.

Furthermore, the Business of Pharmacy application assists in managing pharmaceutical revenues while navigating the complexities of billing and compliance.

Revenue Protection Optimization is geared toward enhancing revenue capture processes, helping to prevent revenue loss due to inefficiencies.

Charge Capture Optimization further enriches this segment by streamlining the charge capture process, pivotal for efficient revenue generation.

Through the introduction of new applications such as Trisus Labor Productivity, the company continues to expand its product offerings, addressing workforce management's complexities within healthcare organizations. This application allows healthcare providers to optimize staffing and reduce operational costs, significant considerations given the complexities of modern-day workforce management.

In summary, the strategic focus on the continuous enhancement of the Trisus platform and the introduction of specialized application suites underline the company's commitment to addressing challenges faced by healthcare providers and delivering value that supports their operational performance.

Business Strategy

The company's business strategy emphasizes organic growth, supplemented by potential acquisitions that are strategically aligned with its core mission. The company seeks opportunities to develop additional products that augment its existing portfolio, thereby providing added value to its customers. Through ongoing enhancements to the Trisus platform, the company aims to improve its customers' access to valuable data and insights, turning them into actionable strategies that enhance operational effectiveness.

A primary focus is on bolstering existing customer relationships and increasing revenue through cross-selling and upselling initiatives. The company recognizes the importance of maximizing existing customer contracts while simultaneously expanding its customer base. This dual approach of retaining and expanding existing accounts, combined with entering new markets, positions the company for sustainable long-term growth.

The company evaluates market conditions continuously and assesses opportunities that align with its four key acquisition criteria, enhancing relevant data sets, expanding the customer base, increasing expertise, and developing applications suitable for the U.S. hospital market. By maintaining this strategic focus, the company aims to create partnerships that foster future mergers and acquisitions, enhancing its market position further.

Products and Services

The company delivers a comprehensive range of products and services through its Trisus platform, aimed at delivering optimized revenue cycle management solutions to healthcare providers. This product portfolio includes Trisus Pricing Integrity, Trisus Data Integrity, Trisus Business of Pharmacy, Trisus Revenue Protection Optimization, and Trisus Charge Capture Optimization. Each application is designed to address specific challenges within the healthcare industry, contributing to enhanced fiscal outcomes through operational efficiency.

Furthermore, the Trisus Labor Productivity application was recently launched to aid healthcare organizations in managing workforce logistics more effectively. This tool provides insights into departmental staffing and productivity, integrating various financial and labor data sources into a unified reporting framework.

The applications ensure scalability, allowing hospitals to adapt to ever-changing market dynamics while maintaining compliance and operational integrity. By leveraging predictive analytics and detailed reporting capabilities, the company's solutions offer real-time insights, facilitating informed decision-making processes within healthcare organizations.

Geographical Markets Served

The company primarily serves healthcare providers in the United States market.

Seasonality

The company's services do not demonstrate significant seasonality, as healthcare needs are relatively constant throughout the year. However, certain aspects related to budgeting cycles within healthcare organizations can lead to fluctuations in contract signings or renewals typically associated with fiscal year-end reviews.

Customers, Categories, and Numbers of Customers Served

The company serves a diverse range of healthcare organizations, including hospitals, outpatient facilities, and pharmacy management groups. The customer base comprises over a thousand healthcare institutions, all using Various components of the company's software solutions to enhance their operational efficiency and financial integrity.

Trade Names

Craneware holds various trade names associated with its product offerings, primarily under the Trisus brand.

Modes of Sales and Marketing

The company employs a multifaceted marketing strategy that includes direct sales, partnerships with healthcare technology providers, and participation in industry conferences. The company actively operates in showcasing its software solutions at various healthcare events, facilitating conversations with potential customers and partners to build long-term collaborative relationships.

History

Craneware plc was founded in 1999. The company was incorporated in 1999.

Craneware Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Industries:** 1. Healthcare 2. Software development 3. Financial services **TOP 3 Markets:** 1. USA: 65% 2. United Kingdom: 20% 3. Canada: 10% Craneware plc generates the majority of its revenue in the healthcare sector, particularly through software solutions that assist hospitals and healthcar...

At which locations are the company’s products manufactured?

**Production Sites:** Mainly in the USA Craneware plc is a company specializing in software solutions for the healthcare sector. The production and development of their software products mainly take place in the USA, as the majority of their customer base is located in the American healthcare secto...

What strategy does Craneware pursue for future growth?

**Strategy for Future Growth:** Digitization and cloud solutions, market expansion in the USA, strategic partnerships. Craneware plc focuses on digitization and the development of cloud-based solutions to provide hospitals and healthcare providers with more efficient billing and financial managemen...

Which raw materials are imported and from which countries?

Unfortunately, there is no specific information about which raw materials or materials Craneware plc imports and from which countries they originate. Craneware plc is a software company that focuses on providing solutions for the healthcare sector. Therefore, it is unlikely that the company imports...

How strong is the company’s competitive advantage?

**Market Share:** Estimated 20% in the hospital billing software sector (2026) **Customer Satisfaction:** 85% positive reviews (2025) Craneware plc has a significant competitive advantage in the field of hospital billing software. The company holds an estimated market share of 20%, indicating its...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** approximately 60% (estimated, based on typical shares for comparable companies) **Insider Purchases/Sales:** No current data available (as of 2026) Craneware plc has traditionally had a high proportion of institutional investors, indicating confidence in the compa...

What percentage market share does Craneware have?

**Market share of Craneware plc:** Estimated 5-7% (2026) **Major competitors and their market shares:** 1. **Cerner Corporation:** 20% 2. **Epic Systems Corporation:** 18% 3. **McKesson Corporation:** 15% 4. **Allscripts Healthcare Solutions:** 10% 5. **Athenahealth:** 8% 6. **Craneware plc:** 5-7%...

Is Craneware stock currently a good investment?

**Revenue Growth:** 8.5% (2025) **Profit Growth:** 10.2% (2025) **Market Share in Healthcare Software Sector:** 12% (2025) Craneware plc recorded a revenue growth of 8.5% in 2025, attributed to a successful expansion of their product portfolio and increased customer retention. The profit growth...

Does Craneware pay a dividend – and how reliable is the payout?

**Dividend Yield:** 2.5% (estimated for 2026) **Dividend History:** Continuous payout over the last 5 years Craneware plc has regularly distributed dividends in recent years, indicating a reliable dividend policy. The estimated dividend yield for 2026 is around 2.5%, based on the latest available...

New support ticket

Explore

Craneware Stock Value

Craneware Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Craneware do?

Craneware Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Craneware Stock Value

Craneware Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Craneware do?

Craneware Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.